ArticleEuropean journal of clinical pharmacology2020

Expression of fibroblast growth factor receptor 4 and clinical response to lenvatinib in patients with anaplastic thyroid carcinoma: a pilot study.

Haruhiko Yamazaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.